Startup compensation is often an opaque and awkward topic for first-time academic founders. How much equity do I receive? My CEO? The PI(s)? Other co-founders? How will my choices affect future compensation?
Tag: university startup
The webinar includes a deep dive on each of the following topics: • Governance and structural concerns of LLCs, including organizational documents, founders’ agreements, and management provisions • Tax issues, including partnership provisions and conversion opportunities for LLCs • Investor concerns on LLCs, particularly from the venture capital lens • Accounting issues on tax and…
Join OUP for a webinar on DEI initiatives for academics and tech transfer managers focused on entrepreneurship and commercialization. You will hear from five leaders in the field discussing programs and initiatives directed at promoting inclusion and dissolving the disparities for underrepresented populations in academic innovation.
For many entrepreneurs, licensing from a university may be a new experience. This series of webinars provides information that will be helpful for academic entrepreneurs contemplating their first (or perhaps subsequent) license from an academic institution. Presented by an attorney who represents many academic startups, including their investors, along with two academic technology transfer veterans, these webinars bring views from both sides of the table and best practices for a fruitful and efficient negotiation.
Corporate VCs have played a crucial role in financing life sciences companies for decades, but have you ever wondered what, if anything, makes them different from institutional venture capital funds? Join us for this webinar as we talk to a panel of investors at industry-leading CVC funds to learn more about their strategies, investment criteria, and how they measure success.
In January of 2020, the U.S. Federal Government issued final rules fully implementing the new powers granted to the Committee on Foreign Investment in the United States (CFIUS). Effective February 13, 2020, the Committee started to exercise its expanded ability to review the national security implications of more foreign investments – in particular companies with ‘novel or advanced technology’ including biotechnology, artificial intelligence, robotics, quantum computing, and advanced materials. New mandatory filing rules are now in place, and the Committee’s new enforcement team – charged with finding unfiled cases within CFIUS’s jurisdiction – is now bringing in far more cases than ever before.
Since its inception in 2009, OUP’s mission has been to foster deep partnerships with universities with three goals in mind: 1) to invest in their spinouts, 2) to help improve technology transfer effectiveness, and 3) to help improve research commercialization by connecting university startups to our network for funding and recruitment opportunities. Please join OUP for an upcoming webinar where we dive into specifics around how we work with our academic partners and continually work to achieve our mission.
A common practice across universities that hold equity in a company that IPOs is to sell all of its shares as soon as the lock up expires. But do the best returns necessarily come from selling all your stock immediately? When is the right time to sell stock in a therapeutics company?
A discussion on the differences in licensing to startups based out of Israel, China, and the UK by experts who have worked in these regions. David Ai, formerly of City University in Hong Kong, Amir Naiberg, formerly of Yeda Research and Development Co, in Israel, and Teri Willey, formerly of Cambridge Enterprise, will talk about particular variances in license clauses and startup structures that US tech transfer offices may encounter when licensing to entities incorporated in these countries.
Hiring top talent is not impossible for startups, but finding the right talent for university spinouts can be a difficult task. Even university startups ensconced in entrepreneurial rich talent-rich pools such as Boston, the Bay area, and New York struggle to appropriately match talent to attractive management roles.